Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated TCM and Western medicine in post-PCI stable coronary heart disease
ChiCTR2100051623Phase 4Not yet recruiting
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Nov 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial of Tao Hong Si Wu Tang in coronary arteriosclerosis and atherosclerotic disease (2 arms), sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Platelet inhibition rate. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
Tao Hong Si Wu Tang
03
Conditions
coronary arteriosclerosisatherosclerotic disease
Beyond the preview
Go deeper on ChiCTR2100051623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051623.